Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study

Human Reproduction

Volumn 19, Issue 6, 2004, Pages 1315-1322

  Kjøtrød, Sigrun B ^a   von During V ^a   Carlsen, S M ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Insulin sensitizers; IVF stimulation; Metformin; OHSS; Polycysctic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; METFORMIN; NAFARELIN; NAFARELIN ACETATE; NORETHISTERONE; PLACEBO; PROGESTERONE; RECOMBINANT FOLLITROPIN; SEX HORMONE BINDING GLOBULIN;

ADULT; AMENORRHEA; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; EMBRYO; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OOCYTE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 3042634808     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh248     Document Type: Article

References (30)

1. Adams J, Polson DW and Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293,355-359.
2. DeLeo V, Marca A, Morgante G and Cianci A (1999) Effects of metformin on gonadotropin induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72,282-285.
3. Diamanti-Kandrakis E, Kouli C, Tsianateli T and Bergiele A (1998) Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138,269-274.
4. Dunaif A, Segal K and Shelly D (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41,1257-1266.
5. El-Biely MM and Habba M. (2001) The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome. Middle East Fertil Soc J 6,43-49.
6. Fedorcsäk P, Dale PO, Storeng R. Åbyholm T and Tanbo T (2003) The effect of metformin on ovarian stimulation and in vitro fertilisation in insulin-resistant women with polycystic ovary syndrome: an open-label randomised cross-over trial. Gynecol Endocrinol 17,207-214.
7. Fleming R, Hopkinson ZE, Wallace AM, Greer I.A and Sattar N (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind, placebo-controlled trial. J Clin Endocrinol Metab 87,569-574.
8. George SS, George K, Irwin C, Job V, Selvakumar R, JeyaseelanV and Seshadri MS (2003) Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomised, controlled trial. Hum Reprod 2,299-304.
9. Glueck CJ, Wang P, Fontaine R, Tracy T and Sieve-Smith L (1999) Metformin-induced resumption of normal menstruation in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 48,511-519.
10. Haas DA, Carr BR and Attia GR (2003) Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 79,469-481.
11. Harborne L, Fleming R, Lyall H, Norman J and Sattar N (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet, 1-8.
12. Hull MGR (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinologic and demographic studies. Gynecol Endocrinol 1,235-245.
13. Kocak M, Caliskan E, Simsir C and Haberal A (2002) Metformin therapy improves ovulatory rates, cervical scores and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77,101-106.
14. Knochenhauer ES, Key TJ, Kashar-Miller M, Waggoner W, Boots LR and Azziz R. (1998) Prevalence of the polycystic ovary syndrome in unselected Black and White women of the south-eastern United States: a prospective study. J Clin Endocrinol Metab 83,3078-3082.
15. Lobo RA, Gysler M, March CM, Goebelsmann U and Mishell DR Jr (1982) Clinical and laboratory predictors of clomiphene response. Fertil Steril 37,168-174.
16. Lord JM, Flight IHK and Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meat-analysis. Br Med. J 327,25.
17. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E and Muggeo M (2000) Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomised double-blind, placebo controlled 6 month trial, followed by open long term clinical evaluation. J Clin Endocrinol Metab 85,139-146.
18. Morin-Papunen LC, Koivunen RM, Ruokonen A.and Martikainen HK (1998) Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 69,691-696.
19. Murakawa H, Hasegawa I, Kurabayashi T and TanakaK (1999) Polycystic ovary syndrome- Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med 44,23-27.
20. Nestler JE, Jakuowich DJ, Evans WS and Pasquali R (1998) Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 338,1876-1880.
21. Ng EH, Wat NM and Ho PC (2001) Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double blinded placebo-controlled trial. Hum Reprod 16,1625-1631.
22. Polson DW, Kiddy DS, Mason HD and Franks S (1989) Induction of ovulation with clomiphenc citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders. Fertil Steril 51,30-34.
23. Stadtmauer LA, Toma SK, Riehl RM and Talbert LM (2001) Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin like growth factors. Fertil Steril 75,505-509.
24. Stadtmauer LA, Toma SK, Riehl RM and Talbert LM (2002a) The impact of metformin on ovarian stimulation and outcome in coasted patients with polycystic ovary syndrome undergoing in-vitro fertilization. RBM Online 5,112-116.
25. Stadtmauer LA, Wong BC and Oehninger S (2002b) Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitising drugs in polycystic ovary syndrome - beyond ovulation induction. Hum Reprod 12,3016-3025.
26. Sturrock NDC, Lannon B and Fay TN (2002) Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br. J Clin Pharmacol 53,469-473.
27. Utiger RD (1996) Insulin and the polycystic ovary syndrome. N Engl J Med 335,657-658.
28. Vandermolen DT, Ratts VS, Evans WS, Stowall DW, Kauma SW and Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75,310-315.
29. Velazquez, E,M, Mendoza S, Hamer T, Sosa F and Glueck CJ (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43,647-654.
30. Yarali,H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O and Koray Z (2002) Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomised trial. Hum Reprod 17, 289-294.